A modified simple, selective, rapid, precise reversed phase high performance liquid chromatography method has been developed and validated for the simultaneous estimation of ketorolac and sparfloxacin. The separation was made in a Hypersil-Keystone C-18 column using a methanol: water (60:40, v/v) (pH 3.1) as mobile phase at 308 nm. The mobile-phase flow rate and the sample volume injected were 0.9 ml/min and 20 µl, respectively. Retention time of sparfloxacin and ketorolac was found to be 3.181 and 4.473 minutes respectively. The correlation coefficient of both drugs was found to be 0.999. The accuracy of ketorolac was found to be 99.82% -100.55% whereas for sparfloxacin, it was 99.76% -99.89%. Over all % RSD was found to be less than 2%. The method was validated according to ICH guidelines with respect to linearity, accuracy, precision, robustness, specificity, etc. The developed method can be used for routine analysis of ketorolac and sparfloxacin in their pharmaceutical dosage forms.
Introduction
Ketorolac or ketorolac trimethamine or 5-amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid ( Figure 1 ) is a well known nonsteroidal anti-inflammatory drug (NSAID) in the family of heterocyclic acetic acid derivatives, often used as an analgesic. Sparfloxacin (SPFX) belongs to the class of fluoroquinolone antibiotics, used in the treatment of bacterial infections that inhibit the bacterial DNA gyrase or the topoisomerase IV enzyme by inhibiting DNA replication and transcription [1] [2] .
Since inflammation can be due to post operative conditions or some microbial infections, a combination of these two drugs can be useful to treat various bacterial infections accompanied by inflammations of various parts of body like dental infection, eye infection etc. Also in the form of eye drops, these drugs can be used ato treat keratitis and conjunctivitis [3] [4] . Therefore, for effective treatment these drugs are usually prescribed in combination. Some HPLC methods have been developed for determination of these drugs individually but no HPLC method for simultaneous estimation of these two drugs using C18 column has been reported till date [5] [6] [7] [8] [9] .
In the present study, an attempt has been made to develop and validate a method for the simultaneous estimation of ketorolac and sparfloxacin, It can also be applied for routine analysis of either one or of any combinations of these drugs in dosage forms.
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Methods

I. Preparation of Standard Solution
Standard stock solutions of sparfloxacin and ketorolac were prepared separately by dissolving 100 mg of drug in 100 ml of methanol to get concentration of 1000 µg/ml. From the standard stock solution, mixed working standard solution was prepared to contain 100 µg/ml of sparfloxacin and 100 µg/ml of ketorolac. Also working stock solution (100 µg/ml) was prepared for both sparfloxacin and ketorolac separately [10] .
II. Preparation of Sample Solution
Ketorolac and Sparfloxacin eye drops were purchased individually from local market with label claim as each ml contains 4 mg of Ketorolac and 3 mg of Sparfloxacin in individual eye drops. 2.5 ml was withdrawn from ketorolac eye drops and diluted with mobile phase to make up the volume to 10 ml in a volumetric flask such that it contained 1000 ketorolac and 3.33 ml was withdrawn from sparfloxacin eye drops and diluted with mobile phase to make up the volume to 10 ml in a volumetric flask such that it contains 1000 sparfloxcin. Both solutions were mixed (working mixture sample solution) to contain 500 µg/ml concentration of Sparfloxacin and 500 µg/ml concentration of Ketorolac. Further dilutions were made to obtain mix solution as concentration 5, 10, 50 further use [10] .
Method Validation [11] I. Linearity and Range
The linearity of an analytical procedure is its ability (within a given range) to obtain test result which are directly proportional to the concentration (amount) of analyte in the sample. It was studied by analyzing five concentrations of the drug in triplicate.
II. Precision
Precision of the system was evaluated by analyzing six independent standard preparations and % RSD value was Standard stock solutions of sparfloxacin and ketorolac were prepared separately by dissolving 100 mg of drug in 100 ml of g/ml. From the standard solution, mixed working standard solution was prepared to µg/ml of ketorolac. g/ml) was prepared for both Ketorolac and Sparfloxacin eye drops were purchased individually from local market with label claim as each ml contains 4 mg of Ketorolac and 3 mg of Sparfloxacin in individual eye drops. 2.5 ml was withdrawn from ketorolac eye th mobile phase to make up the volume to 10 ml in a volumetric flask such that it contained 1000 µg/ml of ketorolac and 3.33 ml was withdrawn from sparfloxacin eye drops and diluted with mobile phase to make up the volume to 10 h that it contains 1000 µg/ml of sparfloxcin. Both solutions were mixed (working mixture sample g/ml concentration of Sparfloxacin and g/ml concentration of Ketorolac. Further dilutions were centration 5, 10, 50 µg/ml for
The linearity of an analytical procedure is its ability (within a given range) to obtain test result which are directly proportional mount) of analyte in the sample. It was studied by analyzing five concentrations of the drug in triplicate.
Precision of the system was evaluated by analyzing six independent standard preparations and % RSD value was calculated to determine any intra-day variation. These studies were also repeated on different days to determine inter variation.
III. Accuracy
To check accuracy of the method, recovery studies were carried out by addition of standard drug solution to pre solution at three different levels 80, 100 and 120 %. Mean percentage recovery was determined.
IV. Limit of detection
The detection limit of an individual analytical procedure is the lowest amount of analyte in a sample, which can be detected but not necessarily quantitated as an exact value. Based on the standard deviation of the response and the slope, detection limit (LOD) may be expressed as:
V. Limit of quantitation
The quantitation limit of an individual analytical procedure is the lowest amount of analyte in a sample, which can be quantitatively determined with suitable precision and accuracy. Based on the standard deviation of the response and the slope, The quantitation limit (LOQ) may be expressed as: LOQ =
S
Where, σ = the standard deviation of the response for the lowest concentration in the range S = the slope of the calibration curve.
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VI. Specificity
The specificity of the method was ascertained by peak purity profiling studies. Purity of the drug was ascertained by analyzing the spectrum at peak start, middle and at peak end. The peak purity was determined on Data Ace Chromatography Work Station Software.
VII. Robustness
Robustness of the method was determined by carrying out by altering mobile phase ratio, chamber saturation time and studying the effects on the area.
VIII. Forced degradation studies
Forced degradation studies of the bulk drug sample were also performed using the following conditions: acid hydrolysis (0.1N HCl), basic hydrolysis (0.1 N NaOH), heat (105°C for 96 hr), photolytic (UV and sunlight for 96 hr), oxidation (30% hydrogen peroxide) and reduction (10% sodium metabisulphite) peak purity test was carried out for Sparfloxacin and Ketorolac by using UV detector.
IX. Degradation under alkali catalyzed hydrolytic condition
A solution of standard drug in 0.1N NaOH at a concentration of 1000 µg/ml was refluxed for 8 hr and then 0.5 ml of the solution was withdrawn and the volume was made up to 10 ml with methanol to get a concentration of 50 µg/ml of working solution.
X. Degradation under acid catalyzed hydrolytic condition
A solution of standard drug in 0.1N HCl, at a concentration of 1000 µg/ml solution was refluxed for 8 hr and then 0.5 ml from the solution was withdrawn and the volume was made up to 10 ml with methanol to get a concentration of 50 µg/ml of working solution.
XI. Degradation under oxidative condition
A solution of standard drug in 30% hydrogen peroxide solution at a concentration of 1000 µg/ml solution was refluxed for 8 hr and then 0.5 ml from the solution was withdrawn and the volume was made up to 10 ml with methanol to get 50 µg/ml working solution.
XII. Degradation under dry heat
Dry heat studies were performed by keeping drug sample in oven (105°C) for a period of 96 hours. Samples were withdrawn after appropriate time, dissolved in methanol and diluted to get 10 µg/ml working solution.
XIII. Photo-degradation studies
Photolytic studies were also carried out by exposure of drug to UV light for a period of 96 hours. Sample was weighed, dissolved and diluted to get 10 µg/ml working solution.
Result and Discussion
Optimization of the mobile phase
Chromatographic separation studies were carried out on the working standard solution of sparfloxacin and ketorolac (100 µg/ml). Initially, trials were carried out using various solvents. After several trials, methanol: water (6:4 v/v) was chosen as the mobile phase, for HPLC, which resulted in good resolution.
Summary of Degradation of Ketorolac
Ketorolac was degraded only on acidic medium ( Figure 9 ) and no degradation was found in basic, oxidation, reduction, thermal, and photolytic condition. In above table the area of Sparfloxacin and Ketorolac at different days are represented. No significant variation in area was found for both drugs, and no other peak was found. Thus, there was no interaction and the standard drug sample was stable till 10 th day.
4.Conclusion
A new method for the simultaneous estimation of ketorolac and sparfloxacin in bulk material, pharmaceutical dosage formulation has been developed for the first time. The proposed RP-HPLC method is simple, rapid, isocratic, specific, accurate and precise. Hence, it can be recommended for the routine quality control.
